Published in Am J Physiol on September 01, 1985
Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors. Proc Natl Acad Sci U S A (1998) 3.07
Biotechnology at low Reynolds numbers. Biophys J (1996) 2.72
Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J Cereb Blood Flow Metab (1996) 1.99
Reiter's syndrome after intravesical Bacillus Calmette-Guérin therapy for bladder cancer. Isr Med Assoc J (2000) 1.97
Esthetic dentistry--a health service? J Dent Res (1993) 1.93
Importance of the design of an exercise protocol in the evaluation of patients with angina pectoris. Circulation (1971) 1.89
Phospholipase C and termination of G-protein-mediated signalling in vivo. Nat Cell Biol (2000) 1.88
Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis. Proc Natl Acad Sci U S A (2001) 1.84
Interindividual variability in sensitivity to warfarin--Nature or nurture? Clin Pharmacol Ther (2001) 1.77
Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger. J Pharmacol Exp Ther (1992) 1.72
Acute takeoffs of the coronary arteries along the aortic wall and congenital coronary ostial valve-like ridges: association with sudden death. J Am Coll Cardiol (1984) 1.69
Thiamine deficiency in patients with congestive heart failure receiving long-term furosemide therapy: a pilot study. Am J Med (1991) 1.63
Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. Life Sci (1981) 1.55
Urinary thiamine excretion in the rat: effects of furosemide, other diuretics, and volume load. J Lab Clin Med (1999) 1.48
Adenosine triphosphate stimulates inositol phospholipid metabolism and prostacyclin formation in adrenal medullary endothelial cells by means of P2-purinergic receptors. Proc Natl Acad Sci U S A (1987) 1.48
Characterization of collagen gel solutions and collagen matrices for cell culture. Biomaterials (2001) 1.44
Trapping and wiggling: elastohydrodynamics of driven microfilaments. Biophys J (1998) 1.44
Treatment of angina pectoris by electrical stimulation of the carotid-sinus nerves. N Engl J Med (1969) 1.43
A new salutary resuscitative fluid: liposome encapsulated hemoglobin/hypertonic saline solution. J Trauma (1993) 1.42
Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. Biochem J (1999) 1.42
Thrombogenic factors and recurrent coronary events. Circulation (1999) 1.38
Circulatory effects of electrical stimulation of the carotid sinus nerves in man. Circulation (1969) 1.38
Laparoscopic adrenalectomy. A new standard of care. Ann Surg (1997) 1.37
Sustained effects of nitroglycerin ointment in patients with angina pectoris. Circulation (1974) 1.34
Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor. Cancer Res (1998) 1.32
Medical management of patients with angina pectoris. Prog Cardiovasc Dis (1972) 1.30
Clinical and circulatory effects of isosorbide dinitrate. Comparison with nitroglycerin. Circulation (1971) 1.29
Twirling and whirling: viscous dynamics of rotating elastic filaments. Phys Rev Lett (2000) 1.29
Effects of a reduction in environmental temperature on the circulatory response to exercise in man. Implications concerning angina pectoris. N Engl J Med (1969) 1.29
Intraoperative coronary collateral function in patients with coronary occlusive disease. Nitroglycerin responsiveness and angiographic correlations. Circulation (1974) 1.27
Impairment of cardiac function in patients with pectus excavatum, with improvement after operative correction. N Engl J Med (1972) 1.25
Beneficial effects of vagal stimulation and bradycardia during experimental acute myocardial ischemia. Circulation (1974) 1.24
2010 ACVIM small animal consensus statement on leptospirosis: diagnosis, epidemiology, treatment, and prevention. J Vet Intern Med (2010) 1.23
Evidence for direct inhibition of de novo purine synthesis in human MCF-7 breast cells as a principal mode of metabolic inhibition by methotrexate. J Biol Chem (1987) 1.19
Potential role of QT interval prolongation in sudden infant death syndrome. Circulation (1976) 1.19
Reduction of ischemic injury by nitroglycerin during acute myocardial infarction. N Engl J Med (1975) 1.17
Selection for spiral waves in the social amoebae Dictyostelium. Proc Natl Acad Sci U S A (1997) 1.13
Impairment of autonomically mediated heart rate control in patients with cardiac dysfunction. Circ Res (1975) 1.13
Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Mol Pharmacol (1999) 1.12
Increased AP-1 activity in drug resistant human breast cancer MCF-7 cells. Breast Cancer Res Treat (1999) 1.12
Breathing 100% oxygen after global brain ischemia in Mongolian Gerbils results in increased lipid peroxidation and increased mortality. Stroke (1987) 1.12
Effect of curcumin on the aryl hydrocarbon receptor and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells. Biochem Pharmacol (1998) 1.10
Blood fibrinolytic activity in man. Diurnal variation and the response to varying intensities of exercise. Circ Res (1970) 1.08
Chiral self-propulsion of growing bacterial macrofibers on a solid surface. Phys Rev Lett (2000) 1.08
Groucho augments the repression of multiple Even skipped target genes in establishing parasegment boundaries. Development (2001) 1.08
Glucagon is a primary controller of hepatic glycogenolysis and gluconeogenesis during muscular work. Am J Physiol (1989) 1.06
Incidence of hyperkalemia in hospitalized patients. Isr J Med Sci (1983) 1.06
Vascular oxidant stress early after balloon injury: evidence for increased NAD(P)H oxidoreductase activity. Free Radic Biol Med (2000) 1.05
Prostacyclin reversal of lethal endotoxemia in dogs. J Clin Invest (1981) 1.05
Study of need for esthetics in dentistry. J Prosthet Dent (1969) 1.05
The relationship of mucosal bacteria to duodenal histopathology, cytokine mRNA, and clinical disease activity in cats with inflammatory bowel disease. Vet Microbiol (2007) 1.04
Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines. Mol Pharmacol (1991) 1.03
Modulation of angiogenesis by dithiolethione-modified NSAIDs and valproic acid. Br J Pharmacol (2007) 1.03
Hemodynamic abnormalities in response to mild and intense upright exercise following operative correction of an atrial septal defect or tetralogy of Fallot. Circulation (1973) 1.02
Reduction in severity and extent of myocardial infarction when nitroglycerin and methoxamine are administered during coronary occlusion. Circulation (1974) 1.01
Labyrinthine pattern formation in magnetic fluids. Science (1993) 0.99
Sympathetic nervous system "switch off" with severe hypothermia. Crit Care Med (1983) 0.99
ARDS-like lung injury produced by endotoxin in platelet-activating factor-primed rats. J Appl Physiol (1985) (1993) 0.98
Vascular effects of lipopolysaccharide are enhanced in interleukin-10-deficient mice. Stroke (1999) 0.98
Prostaglandins, leukotrienes, and platelet-activating factor in shock. Annu Rev Pharmacol Toxicol (1987) 0.98
Bleaching vital teeth: state of the art. Quintessence Int (1989) 0.97
Priming by platelet-activating factor of endotoxin-induced lung injury and cardiovascular shock. Circ Res (1991) 0.97
Comparison of the peak inotropic effects of a catecholamine and a digitalis glycoside in the intact canine heart. Circulation (1970) 0.97
The influence of cold or isolation stress on neuroinvasiveness and virulence of an attenuated variant of West Nile virus. Arch Virol (1989) 0.97
Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism. Biochem Pharmacol (1994) 0.97
Purified human erythrocyte pyrroline-5-carboxylate reductase. Preferential oxidation of NADPH. J Biol Chem (1989) 0.97
Exercise-induced fall in insulin and hepatic carbohydrate metabolism during muscular work. Am J Physiol (1989) 0.96
The effect of pyrroline-5-carboxylic acid on nucleotide metabolism in erythrocytes from normal and glucose-6-phosphate dehydrogenase-deficient subjects. J Biol Chem (1984) 0.96
Stimulation of the hexosemonophosphate-pentose pathway by pyrroline-5-carboxylate in cultured cells. J Cell Physiol (1982) 0.96
Influence of sulfinpyrazone and naproxen on infarct size in the dog. Am J Cardiol (1981) 0.95
Vascular NAD(P)H oxidase is distinct from the phagocytic enzyme and modulates vascular reactivity control. Am J Physiol Heart Circ Physiol (2001) 0.95
The function of pyrroline-5-carboxylate reductase in human erythrocytes. Biochem Biophys Res Commun (1980) 0.95
Stroke risk factors prepare rat brainstem tissues for modified local Shwartzman reaction. Stroke (1988) 0.95
Oxidative stress as a signaling mechanism of the vascular response to injury: the redox hypothesis of restenosis. Cardiovasc Res (2000) 0.95
DNA damage and cell cycle arrest induced by 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F 203, NSC 703786) is attenuated in aryl hydrocarbon receptor deficient MCF-7 cells. Br J Cancer (2003) 0.94
Postoperative assessment of patients with ventricular septal defect and pulmonary hypertension. Response to intense upright exercise. Circulation (1973) 0.94
Psychosis with ordinary doses of propranolol. Ann Intern Med (1979) 0.94
Protein turnover and energy expenditure increase during exogenous nutrient availability in sickle cell disease. Am J Clin Nutr (1998) 0.93
Role of complement in endotoxin/platelet-activating factor-induced lung injury. J Immunol (1992) 0.93
Shortened platelet survival time and enhanced heart rate responses after abrupt withdrawal of propranolol from normal subjects. Am J Cardiol (1981) 0.93
Alterations in the circulatory response to exercise following a meal and their relationship to postprandial angina pectoris. Circulation (1971) 0.93
Influence of atropine and of vagally mediated bradycardia on the occurrence of ventricular arrhythmias following acute coronary occlusion in closed-chest dogs. Circulation (1973) 0.93
Transfer of 1-pyrroline-5-carboxylate as oxidizing potential from hepatocytes to erythrocytes. Biochem J (1982) 0.93
Leukotrienes and the cardiovascular system. Prostaglandins (1984) 0.92
Neuroprotective effects of SKF 10,047 in cultured rat cerebellar neurons and in gerbil global brain ischemia. Stroke (1992) 0.92
Laparoscopic adrenalectomy: 100 resections with clinical long-term follow-up. Surg Endosc (2004) 0.92
Pyrroline-5-carboxylate reductase in human erythrocytes. J Clin Invest (1981) 0.92
An improved clinically relevant sepsis model in the conscious rat. Crit Care Med (2000) 0.92
Voltage-sensitive calcium flux into bovine chromaffin cells occurs through dihydropyridine-sensitive and dihydropyridine- and omega-conotoxin-insensitive pathways. Neuroscience (1989) 0.92
Preferential secretion of adrenaline or noradrenaline by the cat adrenal in vivo in response to different stimuli. Br J Pharmacol (1971) 0.92
Diosmin and diosmetin are agonists of the aryl hydrocarbon receptor that differentially affect cytochrome P450 1A1 activity. Cancer Res (1998) 0.92
Hypothalamic sites for cardiovascular and sympathetic modulation by prostaglandin E2. Brain Res (1982) 0.91
Inhibition of P-glycoprotein activity and reversal of multidrug resistance in vitro by rosemary extract. Eur J Cancer (1999) 0.91
Quantitation of perivascular monocytes and macrophages around cerebral blood vessels of hypertensive and aged rats. J Cereb Blood Flow Metab (1994) 0.91
Accumulation of gallium-67 in regions of acute myocardial infarction. Am J Cardiol (1974) 0.91
Lack of effect of aspirin on myocardial infarct size in the dog. Am J Cardiol (1981) 0.90
Effects of PAF and BN 52021 on cardiac function and regional blood flow in conscious rats. Am J Physiol (1989) 0.90
Mu-receptors mediate opioid cardiovascular effects at anterior hypothalamic sites through sympatho-adrenomedullary and parasympathetic pathways. Endocrinology (1983) 0.90